Foto del docente

Andrea Ardizzoni

Professore ordinario

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: MEDS-09/A Oncologia medica

Pubblicazioni

Gelsomino, Francesco; Lamberti, Giuseppe; Parisi, Claudia; Casolari, Laura; Melotti, Barbara; Sperandi, Francesca; Ardizzoni, Andrea, The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers, «CANCER TREATMENT REVIEWS», 2019, 79, Article number: 101887, pp. 1 - 11 [articolo]

Gelfo V, Mazzeschi M, Grilli G, Lindzen Moshit, Santi Spartaco, D'Uva G, Győrffy B, Ardizzoni A, Yarden Y, Lauriola M., A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy, «CANCERS», 2018, 10, pp. 355 - 370 [articolo]

Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E, Ardizzoni A, Massari F, A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor., «ANTI-CANCER DRUGS», 2018, 29, pp. 911 - 913 [articolo]

Gelsomino, Francesco*; Vitale, Giovanni; Ardizzoni, Andrea, A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event, «INVESTIGATIONAL NEW DRUGS», 2018, 36, pp. 144 - 146 [articolo]

Ferrarini A, Forcato C, Buson G, Tononi P, Del Monaco V, Terracciano M, Bolognesi C, Fontana F, Medoro G, Neves R, Möhlendick B, Rihawi K, Ardizzoni A, Sumanasuriya S, Flohr P, Lambros M, de Bono J, Stoecklein NH, Manaresi N, A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products., «PLOS ONE», 2018, 1, Article number: e0193689, pp. 1 - 24 [articolo]Open Access

Morgensztern, Daniel*; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E.; Lewanski, Conrad R.; Bennouna, Jaafar; Fischer, Jürgen R.; Juan-Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C.; Jin Ong, Teng; Govindan, Ramaswamy, ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC), «CANCER», 2018, 124, pp. 4667 - 4675 [articolo]

Dall'Olio, Filippo Gustavo; Sperandi, Francesca; Rihawi, Karim; Gargiulo, Mauro; Melotti, Barbara; Brocchi, Stefano; Gelsomino, Francesco*; Ardizzoni, Andrea, Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding, «JOURNAL OF THORACIC ONCOLOGY», 2018, 13, pp. e247 - e248 [articolo]

Goss GD, Felip E , Cobo M, Lu S, Syrigos K, Lee KH, Göker E, Georgoulias V, Li W, Guclu S, Isla D, Min YJ, Morabito A, Ardizzoni A, Gadgeel SM, Fülöp A, Bühnemann C, Gibson N, Krämer N, Solca F, Cseh A, Ehrnrooth E, Soria JC., Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial., «JAMA ONCOLOGY», 2018, 4, pp. 1189 - 1197 [articolo]

Cinausero, Marika; Rihawi, Karim*; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea, Chemotherapy treatment in malignant pleural mesothelioma: A difficult history, «JOURNAL OF THORACIC DISEASE», 2018, 10, pp. S304 - S310 [replica/breve intervento]

Massari, Francesco*; Di Nunno, Vincenzo; Comito, Francesca; Cubelli, Marta; Ciccarese, Chiara; Iacovelli, Roberto; Fiorentino, Michelangelo; Montironi, Rodolfo; Ardizzoni, Andrea, Circulating tumor cells in genitourinary tumors, «THERAPEUTIC ADVANCES IN UROLOGY», 2018, 10, pp. 65 - 77 [articolo]

Facchinetti, Francesco*; Veneziani, Michele; Buti, Sebastiano; Gelsomino, Francesco; Squadrilli, Anna; Bordi, Paola; Bersanelli, Melissa; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Mazzaschi, Giulia; Leonardi, Francesco; Quaini, Federico; Ardizzoni, Andrea; Missale, Gabriele; Tiseo, Marcello, Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab, «IMMUNOTHERAPY», 2018, 10, pp. 681 - 694 [articolo]

Vincenzo Di Nunno; Veronica Mollica; Beniamino Corcioni; Michelangelo Fiorentino; Elisabetta Nobili; Riccardo Schiavina; Rita Golfieri; Eugenio Brunocilla; Andrea Ardizzoni; Francesco Massari, Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma., «ANTI-CANCER DRUGS», 2018, 29, pp. 710 - 715 [articolo]

Rihawi K, Cinausero M, Fiorentino M, Salvagni S, Brocchi S, Ardizzoni A, Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins, «JOURNAL OF THORACIC ONCOLOGY», 2018, 13, pp. 41 - 43 [articolo]

Dall'Olio, Filippo Gustavo*; Brocchi, Stefano; Massucci, Maria; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea, Distinguishing between immune-related pneumonitis and disease progression in advanced Non Small Cell Lung Cancer treated with PD-1 inhibitors: Can serum tumour markers have a role?, «EUROPEAN JOURNAL OF CANCER», 2018, 95, pp. 127 - 129 [articolo]

Giunchi F; Degiovanni A; Daddi N; Trisolini R; Dell'Amore A; Agostinelli C; Ardizzoni A; Fiorentino M, Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study, «APPLIED IMMUNOHISTOCHEMISTRY AND MOLECULAR MORPHOLOGY», 2018, 26, pp. 489 - 494 [articolo]